BackAllied Biotech Overview

Allied Biotech Total Assets

Track Allied Biotech's total assets ($2.6B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$2.56B
↑ 10.57% YoYΔ $244.36M vs prior year quarter

Peer trimmed avg / median

Loading

Allied Biotech Total Assets History

Loading

Allied Biotech vs. peers: Total Assets Comparison

Loading

Allied Biotech Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Allied Biotech (1780.TWO) FAQ

Allied Biotech posts a total assets of $2.6B as of June 2026. That compares with $2.3B in the prior-year period — up 10.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Allied Biotech's total assets was $2.3B. The latest reading is $2.6B — a 10.6% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Allied Biotech's financial statement story. At $2.6B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 1780.TWO's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Allied Biotech's other metric pages and overview cover the third.